Skip to main content
Top
Published in: Endocrine 3/2019

01-12-2019 | Obesity | Original Article

Body muscle-to-fat ratio gender-specific cut-off values for impaired insulin sensitivity in patients with treatment-naïve type 2 diabetes mellitus

Authors: Noboru Kurinami, Seigo Sugiyama, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouch, Tomio Jinnouchi, Hideaki Jinnouchi

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Purpose

We previously reported that the body muscle-to-fat ratio (BMFR), measured using bioelectrical impedance, significantly correlated with whole-body insulin sensitivity. We examined BMFR gender-specific cut-off values for impaired insulin sensitivity in treatment-naïve type 2 diabetes mellitus (T2DM) patients.

Methods

Subjects included 101 untreated T2DM patients (male, 66; female, 35). We performed a hyperinsulinemic–euglycemic clamp examination to measure the steady-state glucose infusion rate (M value) as an indicator of whole-body insulin resistance. We defined the M value divided by the steady-state serum insulin value as the M/I value. We defined the existence of insulin resistance using an M/I ratio <9.0. The optimal cut-off value for BMFR was calculated by receiver operating characteristics (ROC) analysis.

Results

The cut-off value of the BMFR for insulin resistance was 2.75 (area under the curve [AUC] = 0.83, sensitivity 75%, and specificity 76%, P < 0.001) for males and 1.65 (AUC = 0.87, sensitivity 84%, and specificity 81%, P < 0.001) for females. Simple linear regression analysis showed that BMFR was significantly correlated with the M/I value in both genders (males, B = 0.77, P< 0.01; females, B = 0.83, P< 0.01).

Conclusions

BMFR cut-off values for impaired insulin sensitivity in treatment-naïve T2DM patients were 2.75 for males and 1.65 for females.
Literature
1.
go back to reference E.S. Ford, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28, 2745–2749 (2005)CrossRef E.S. Ford, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28, 2745–2749 (2005)CrossRef
2.
go back to reference A. Galassi, K. Reynolds, J. He, Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119, 812–819 (2006)CrossRef A. Galassi, K. Reynolds, J. He, Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119, 812–819 (2006)CrossRef
3.
go back to reference A.S. Gami, B.J. Witt, D.E. Howard, P.J. Erwin, L.A. Gami et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49, 403–414 (2007)CrossRef A.S. Gami, B.J. Witt, D.E. Howard, P.J. Erwin, L.A. Gami et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49, 403–414 (2007)CrossRef
4.
go back to reference N. Kurinami, S. Sugiyama, A. Yoshida, K. Hieshima, F. Miyamoto et al. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic–euglycemic clamp in treatment-naïve type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 120, 65–72 (2016)CrossRef N. Kurinami, S. Sugiyama, A. Yoshida, K. Hieshima, F. Miyamoto et al. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic–euglycemic clamp in treatment-naïve type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 120, 65–72 (2016)CrossRef
5.
go back to reference S. Kawanabe, Y. Nagai, Y. Nakamura, A. Nishine, T. Nakagawa et al. Association of the muscle/fat mass ratio with insulin resistance in gestational diabetes mellitus. Endocr. J. 66, 75–80 (2019)CrossRef S. Kawanabe, Y. Nagai, Y. Nakamura, A. Nishine, T. Nakagawa et al. Association of the muscle/fat mass ratio with insulin resistance in gestational diabetes mellitus. Endocr. J. 66, 75–80 (2019)CrossRef
6.
go back to reference G. Enzi, M. Gasparo, P.R. Biondetti, D. Fiore, M. Semisa et al. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44, 739–746 (1986)CrossRef G. Enzi, M. Gasparo, P.R. Biondetti, D. Fiore, M. Semisa et al. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44, 739–746 (1986)CrossRef
7.
go back to reference H. Jinnouchi, S. Sugiyama, K. Hieshima, N. Kurinami, K. Kajiwara et al. Liraglutide, a glucagon-like peptide-1 analog, increased insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination in patients with uncontrolled type 2 diabetes mellitus. J. Diabetes Res. 706416 (2015). https://doi.org/10.1155/2015/706416.CrossRef H. Jinnouchi, S. Sugiyama, K. Hieshima, N. Kurinami, K. Kajiwara et al. Liraglutide, a glucagon-like peptide-1 analog, increased insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination in patients with uncontrolled type 2 diabetes mellitus. J. Diabetes Res. 706416 (2015). https://​doi.​org/​10.​1155/​2015/​706416.CrossRef
8.
go back to reference H. Yki-Järvinen, V.A. Koivisto, Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J. Clin. Endocrinol. Metab. 59, 371–378 (1984)CrossRef H. Yki-Järvinen, V.A. Koivisto, Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J. Clin. Endocrinol. Metab. 59, 371–378 (1984)CrossRef
9.
go back to reference R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 273, E214–E223 (1979) R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 273, E214–E223 (1979)
10.
go back to reference N. Kurinami, S. Sugiyama, H. Nishimura, A. Morita, A. Yoshida et al. Clinical factors associated with initial decrease in body-fat percentage induced by add-on sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus. Clin. Drug Investig. 38, 19–27 (2018)CrossRef N. Kurinami, S. Sugiyama, H. Nishimura, A. Morita, A. Yoshida et al. Clinical factors associated with initial decrease in body-fat percentage induced by add-on sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus. Clin. Drug Investig. 38, 19–27 (2018)CrossRef
11.
go back to reference N. Kurinami, S. Sugiyama, A. Yoshida, K. Hieshima, F. Miyamoto et al. Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 142, 254–263 (2018)CrossRef N. Kurinami, S. Sugiyama, A. Yoshida, K. Hieshima, F. Miyamoto et al. Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 142, 254–263 (2018)CrossRef
12.
go back to reference K. Cha, G.M. Chertow, J. Gonzalez, J.M. Lazarus, D.W. Wilmore, Multifrequency bioelectrical impedance estimates the distribution of body water. J. Appl. Physiol. 79, 1316–1319 (1995)CrossRef K. Cha, G.M. Chertow, J. Gonzalez, J.M. Lazarus, D.W. Wilmore, Multifrequency bioelectrical impedance estimates the distribution of body water. J. Appl. Physiol. 79, 1316–1319 (1995)CrossRef
13.
go back to reference K. Cha, S. Shin, C. Shon, S. Choi, D.W. Wilmore, Evaluation of segmental bioelectrical impedance analysis (SIBA) for measuring muscle distribution. J. ICHPER SD 1, 11–14 (1997) K. Cha, S. Shin, C. Shon, S. Choi, D.W. Wilmore, Evaluation of segmental bioelectrical impedance analysis (SIBA) for measuring muscle distribution. J. ICHPER SD 1, 11–14 (1997)
14.
go back to reference A. Fürstenberg, A. Davenport, Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients. Am. J. Kidney Dis. 57, 123–129 (2011)CrossRef A. Fürstenberg, A. Davenport, Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients. Am. J. Kidney Dis. 57, 123–129 (2011)CrossRef
15.
go back to reference Q. Guo, C. Yi, J. Li, X. Wu, X. Yang et al. Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS ONE 8, e53294 (2013)CrossRef Q. Guo, C. Yi, J. Li, X. Wu, X. Yang et al. Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS ONE 8, e53294 (2013)CrossRef
16.
go back to reference J. Cobb, W. Gall, K.P. Adam, P. Nakhle, E. Button et al. A novel fasting blood test for insulin resistance and prediabetes. J. Diabetes Sci. Technol. 7, 100–110 (2013)CrossRef J. Cobb, W. Gall, K.P. Adam, P. Nakhle, E. Button et al. A novel fasting blood test for insulin resistance and prediabetes. J. Diabetes Sci. Technol. 7, 100–110 (2013)CrossRef
17.
go back to reference J.P. Frias, G.B. Macaraeg, J. Ofrecio, J.G. Yu, J.M. Olefsky et al. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 50, 1344–1350 (2001)CrossRef J.P. Frias, G.B. Macaraeg, J. Ofrecio, J.G. Yu, J.M. Olefsky et al. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 50, 1344–1350 (2001)CrossRef
18.
go back to reference A.M. Lundsgaard, B. Kiens, Gender differences in skeletal muscle substrate metabolism—molecular mechanisms and insulin sensitivity. Front. Endocrinol. 5, 195 (2014)CrossRef A.M. Lundsgaard, B. Kiens, Gender differences in skeletal muscle substrate metabolism—molecular mechanisms and insulin sensitivity. Front. Endocrinol. 5, 195 (2014)CrossRef
19.
go back to reference J. Park, S. Kim, Validity of muscle-to-fat ratio as a predictor of adult metabolic syndrome. J. Phys. Ther. Sci. 28, 1036–1045 (2016)CrossRef J. Park, S. Kim, Validity of muscle-to-fat ratio as a predictor of adult metabolic syndrome. J. Phys. Ther. Sci. 28, 1036–1045 (2016)CrossRef
20.
go back to reference N. Kurinami, S. Sugiyama, M. Ayami, A. Yoshida, K. Hieshima et al. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 139, 122–130 (2018)CrossRef N. Kurinami, S. Sugiyama, M. Ayami, A. Yoshida, K. Hieshima et al. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 139, 122–130 (2018)CrossRef
21.
go back to reference N. Kurinami, S. Sugiyama, H. Ijima, A. Yoshida, K. Hieshima et al. Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 143, 134–139 (2018)CrossRef N. Kurinami, S. Sugiyama, H. Ijima, A. Yoshida, K. Hieshima et al. Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 143, 134–139 (2018)CrossRef
Metadata
Title
Body muscle-to-fat ratio gender-specific cut-off values for impaired insulin sensitivity in patients with treatment-naïve type 2 diabetes mellitus
Authors
Noboru Kurinami
Seigo Sugiyama
Akira Yoshida
Kunio Hieshima
Fumio Miyamoto
Keizo Kajiwara
Katsunori Jinnouch
Tomio Jinnouchi
Hideaki Jinnouchi
Publication date
01-12-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02092-8

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.